Consequently, silencing IKBKE has been reported to reduce the NF-κB activity and inhibit proliferation, clonogenicity, angiogenesis, migration, invasion, and metastasis in BC cells and many other cancer types [117,121]. The gene discussed is NFKB1; the disease is cancer.